Hunter Biden Details Father's Ongoing Prostate Cancer Battle

Hunter Biden described his father’s cancer as having spread and become increasingly painful in a recent BBC interview, offering a candid update on the former president’s health more than a year after his initial diagnosis. The 83-year-old Joe Biden announced prostate cancer in May 2025, and subsequent treatments have included surgery for skin cancer lesions and radiation therapy. Hunter Biden told the BBC’s Newsnight that the disease has metastasized into the bones and beyond, calling the effects “very painful” and “very debilitating in many respects,” while noting that his father continues to remain active in line with his long-held belief in public service.

The younger Biden’s remarks come amid a series of family reflections on the disease. In a separate appearance on SiriusXM, Jill Biden characterized the condition as a persistent challenge requiring regular testing and medication every three months. She emphasized that the experience mirrors earlier family encounters with cancer, including the 2015 death of their son Beau from glioblastoma. “He will live forever with cancer,” she said, describing the daily demands as both constant and demanding for everyone involved.

These statements contrast with earlier public comments from Joe Biden himself. When promoting a forthcoming memoir last month, the former president indicated that treatment was progressing positively and expressed appreciation for public support. The gap between those remarks and the more recent descriptions from his family highlights how health updates from high-profile figures often balance private realities with public messaging. Hunter Biden did not specify additional sites of metastasis, and representatives for the former president have not released further medical details.

The interviews also touched on broader family dynamics. Hunter Biden pushed back against suggestions that his own legal troubles had distracted his father, insisting that Joe Biden has always weighed decisions with both family and national interests in mind. He rejected the notion that anyone could simply “take the keys away” from a president, framing his father’s choices as deliberate and independent.

For public figures who have spent decades in the spotlight, managing a progressive illness involves repeated adjustments to routine and expectations. Joe Biden’s case follows a pattern seen with other former officeholders who continue limited engagement after leaving office, even as treatment schedules shape their days. The family’s history with cancer adds another layer, turning medical updates into reminders of earlier losses. Observers note that such disclosures can influence how voters and institutions think about the physical demands placed on leaders well into their eighties, though the focus here remains on the personal toll rather than political speculation.

Jill Biden has spoken of the condition as an enduring part of life rather than a temporary episode, a perspective that aligns with clinical understandings of metastatic prostate cancer, which often requires ongoing management. Hunter Biden’s description of the pain and physical limits underscores the daily trade-offs involved, even as he portrayed his father as still committed to the country. The family’s willingness to discuss these matters publicly may reflect a desire to normalize conversations around aging and illness among political figures.

As treatment continues, the Bidens have stressed gratitude for medical care and public well-wishes. The former president’s post-presidency activities appear shaped by both the disease and the family’s experience with it, producing a period of measured engagement rather than full withdrawal. Future updates will likely continue to balance clinical information with personal context, consistent with how other prominent families have handled similar situations over time.